Last reviewed · How we verify
NCT04039555: COER
Clinical Study to Compare the Efficacy of Erbium-Yag Laser or CO2RE Intimate Laser With Sham (COER)
NA trial testing CO2 intimate in Vaginal Atrophy in 136 participants. Completed in 30 May 2020.
31 March 2020
Quick facts
| Lead sponsor | Instituto Palacios |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 136 |
| Start date | 24 September 2019 |
| Primary completion | 31 March 2020 |
| Estimated completion | 30 May 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- CO2 intimate
- Erbium-yag
- CO2 intimate or Erbium-yag
Conditions studied
- Vaginal Atrophy — all drugs for Vaginal Atrophy →
Sponsor
Instituto Palacios — full company profile →
Who can join
45 and older, female only, with Vaginal Atrophy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial compares the efficacy of two different laser treatments for vaginal atrophy symptoms between them and with sham treatment. Patients will be randomized to one of the two lasers or sham treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04039555
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaginal Atrophy
Currently open trials in the same condition.
- NCT05457972 — Postpartum Vaginal Estrogen for Breastfeeding Patients · Phase 4 · recruiting
- NCT06028009 — PRP Injections for Genitourinary Syndrome of Menopause · NA · active not recruiting
- NCT07024667 — Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vagin · NA · recruiting
- NCT05335317 — Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser · NA · recruiting
- NCT04807894 — Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo · Phase 4 · recruiting
Other Instituto Palacios trials
Trials by the same sponsor.
- NCT04232813 — Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream · Phase 3 · completed
- NCT03385551 — Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream · completed
- NCT03923985 — Clinical Trial to Evaluate the Effect of an Oral Probiotic on the Vaginal Flora · NA · completed
- NCT03452696 — Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04039555 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Palacios
- Last refreshed: 11 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04039555.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing